Published in J Am Coll Cardiol on February 01, 2005
Study of Unprotected Left Main Stenting Versus Bypass Surgery (LE MANS Study) | NCT00375063
Angioplasty of unprotected left main coronary stenosis: Real world experience of a single-operator group from eastern India. Indian Heart J (2016) 1.07
The significance of clopidogrel low-responsiveness on stent thrombosis and cardiac death assessed by the verifynow p(2)y(12) assay in patients with acute coronary syndrome within 6 months after drug-eluting stent implantation. Korean Circ J (2009) 0.99
The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry. Clin Res Cardiol (2007) 0.98
Extrinsic compression of the left coronary ostium by the pulmonary trunk: management in a case of Eisenmenger syndrome. Tex Heart Inst J (2010) 0.89
Rosuvastatin reduces neointima formation in a rat model of balloon injury. Eur J Med Res (2010) 0.82
Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents. Heart Vessels (2010) 0.81
Comparison of the efficacy of drug-eluting stents versus bare-metal stents for the treatment of left main coronary artery disease. Chin Med J (Engl) (2015) 0.80
Evaluation of Percutaneous Coronary Intervention and stenting of Left Main Coronary Artery Stenosis in Tehran's Rajaie and Lavasani Hospitals from 2010 to 2011. Res Cardiovasc Med (2013) 0.80
Will drug-eluting stents replace coronary artery bypass surgery? Tex Heart Inst J (2005) 0.80
Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry. Clin Res Cardiol (2010) 0.80
Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation. Heart (2007) 0.80
Clinical outcome and quality of life after interventional treatment of left main disease with drug-eluting-stents in comparison to CABG in elderly and younger patients. Clin Res Cardiol (2010) 0.79
Percutaneous coronary artery stenting of unprotected left main coronary artery disease using drug-eluting stents: the initial Baylor University Medical Center experience. Proc (Bayl Univ Med Cent) (2007) 0.78
Impact of the bifurcation angle on major cardiac events after cross-over single stent strategy in unprotected left main bifurcation lesions: 3-dimensional quantitative coronary angiographic analysis. Am J Cardiovasc Dis (2014) 0.78
On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes. Tex Heart Inst J (2012) 0.78
Percutaneous coronary intervention for unprotected left main coronary artery stenosis. World J Cardiol (2010) 0.78
STENTING STRATEGY AND FOLLOW-UP RESULTS OF MULTI-CENTER REGISTRY IN FUKUSHIMA CITY FOR LEFT MAIN CORONARY ARTERY DISEASE: BARE METAL STENT VERSUS DRUG-ELUTING STENT. Fukushima J Med Sci (2015) 0.78
Unprotected left main coronary artery intervention for acute myocardial infarction and cardiogenic shock. Tex Heart Inst J (2007) 0.78
Comparison of bypass surgery with drug-eluting stents in diabetic patients with left main coronary stenosis. Yonsei Med J (2011) 0.76
Real World Application of Stenting of Unprotected Left Main Coronary Stenosis: A Single-Center Experience. Cardiol Res (2012) 0.75
Comparison of coronary artery bypass grafting with percutaneous coronary intervention for unprotected left main coronary artery disease. Yonsei Med J (2012) 0.75
Left Main PCI, Still a Main Issue. Res Cardiovasc Med (2013) 0.75
Revascularization for unprotected left main coronary artery disease: an evolution in clinical decision making. Curr Cardiol Rep (2011) 0.75
Stenting versus bypass surgery for the treatment of left main coronary artery disease. Yonsei Med J (2009) 0.75
Stenting of left main coronary artery stenosis: A to Z. Heart Asia (2013) 0.75
Left main coronary artery thrombectomy and stenting using a paclitaxel-eluting stent in the setting of acute myocardial infarction. Can J Cardiol (2006) 0.75
Comparison of clinical outcomes after drug-eluting stent implantation in diabetic versus nondiabetic patients in China: A retrospective study. Medicine (Baltimore) (2017) 0.75
One-stent versus two-stent techniques for distal unprotected left main coronary artery bifurcation lesions. Int J Clin Exp Med (2015) 0.75
Clinical comparison of percutaneous coronary intervention with domestic drug-eluting stents versus off pump coronary artery bypass grafting in unprotected left main coronary artery disease. Int J Clin Exp Med (2015) 0.75
One-Year Outcomes After Everolimus-Eluting Stents Implantation in Ostial Lesions of Left Anterior Descending Coronary Arteries. Cardiol Res (2014) 0.75
Study of Short and Intermediate Term Clinical Outcomes of Patients with Protected and Unprotected LMCA Stenting. J Clin Diagn Res (2017) 0.75
Effect of stents coated with a combination of sirolimus and alpha-lipoic acid in a porcine coronary restenosis model. J Mater Sci Mater Med (2016) 0.75
A prospective natural-history study of coronary atherosclerosis. N Engl J Med (2011) 10.66
Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med (2010) 6.37
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol (2004) 5.67
Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med (2008) 4.96
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol (2002) 4.94
Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol (2012) 4.29
Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med (2015) 4.27
Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol (2004) 3.67
Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med (2011) 3.55
Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol (2006) 3.45
Long-term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc Interv (2011) 3.38
Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv (2009) 3.36
In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol (2010) 2.85
Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation (2003) 2.72
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial. Circulation (2013) 2.55
Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation (2011) 2.46
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol (2005) 2.42
Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity. Circ Cardiovasc Interv (2011) 2.35
Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol (2007) 2.32
A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. JACC Cardiovasc Interv (2009) 2.30
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol (2012) 2.28
Stroke risk after coronary artery bypass graft surgery and extent of cerebral artery atherosclerosis. J Am Coll Cardiol (2011) 2.23
Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol (2003) 2.18
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC Cardiovasc Interv (2009) 2.12
A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med (2003) 2.07
Late target lesion revascularization after implantation of sirolimus-eluting stent. Catheter Cardiovasc Interv (2008) 2.03
Prevalence of angiographically defined obstructive coronary artery disease in asymptomatic patients with type 2 diabetes according to the coronary calcium score. Intern Med (2012) 2.02
The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol (2010) 1.90
Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol (2010) 1.86
Incidence, morphology, angiographic findings, and outcomes of intramural hematomas after percutaneous coronary interventions: an intravascular ultrasound study. Circulation (2002) 1.79
Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol (2003) 1.77
Prognostic value of longitudinal strain after primary reperfusion therapy in patients with anterior-wall acute myocardial infarction. J Am Soc Echocardiogr (2007) 1.74
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol (2005) 1.73
Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. J Am Coll Cardiol (2005) 1.72
Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation (2004) 1.72
The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation. JACC Cardiovasc Interv (2010) 1.72
C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation. Circulation (2009) 1.69
Saphenous vein graft intervention. JACC Cardiovasc Interv (2011) 1.69
Preintervention angiographic and intravascular ultrasound predictors for side branch compromise after a single-stent crossover technique. Am J Cardiol (2011) 1.67